Facilitating Access to Approved Medication

Pembrolizumab Injection 100 mg
Pembrolizumab Injection is used in: Patients whose cancer cannot be removed by surgery or has metastasized (spread to other parts of the body).

Get Access To Pembrolizumab Injection 100 mg

Pembrolizumab Injection was approved for medical use in the United States in 2014. It is on the World Health Organization’s List of Essential Medicines.

Pembrolizumab Injection Available Price In India UK Saudi Arabia

Pembrolizumab Injection

  • API – Pembrolizumab
  • Packaging – Glass Bottle
  • Strength – 100 mg
  • Brand name Available – On Request

What is Pembrolizumab used for?

Pembrolizumab Injection, Keytruda is a prescription medicine used to treat the symptoms of Melanoma and for many other cancer types such as Non Small Lung Cancer, Head and Neck Squamous Cell Cancer, Classical Hodgkin Lymphoma, and Primary Medistinal Large B-Cell Lymphoma. Keytruda may be used alone or with other medications.

    Disclaimer

    All Trademarks and Brands that appear on website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.

    Get Access To Pembrolizumab Injection 100 mg

    Lucknow Speciality Pharma, Lucknow, India

    Lucnow Speciality Pharma is registered in Lucknow, India. Registration Number : AAKFL2122J1ZB Under GST Act
    Branch Offices in India : Lucknow | Agra | Jaipur | Varanasi | New Delhi

    2nd Floor, 203-A, Felix Square, Golf City, Gomti Nagar, Lucknow, Uttar Pradesh 226030

    Mobile :+91 97600 14849 / 9555306364
    WhatsApp :+91 97600 14849 / 9555306364

    Facts of Medicines

    Pembrolizumab Injection 100 mg

    HOW SUPPLIED/STORAGE AND HANDLING:

    Pembrolizumab must be refrigerated at 2°C to 8°C (36°F to 46°F). Do not use the Pembrolizumab beyond the expiration date located on the carton and the vial.

    DOSAGE

    Injection: 100 mg/4 mL (25 mg/mL) solution in a single-dose vial .

    SIDE EFFECTS

    The following clinically significant adverse reactions can occur with Pembrolizumab: Cardiovascular Toxicity, Myelosuppression, Hypersensitivity, Hypertension, Pancreatic Toxicity.

    WARNINGS AND PRECAUTIONS

    • Genetic testing should be indicated in order to detect whether a person is at higher risk of developing hypersensitivity.
    • Pembrolizumab may not be added as a single agent when antiretroviral regimens are changed because of loss of the virologic response.
    • Patients with liver disease should be watchful and cautious in order to Pembrolizumab because it can aggravate the condition.
    • In patients with Pembrolizumab, conditions like immune reconstitution inflammatory syndrome, a change in body fat as well as an increased risk of heart attack may occur.
    • Pembrolizumab is not recommended for use in infants who are under 3 months of age.
    • Cases like lactic acidosis and severe hepatomegaly with steatosis occurred with the use of nucleoside analogues.
    • Sometimes serious hypersensitivity reactions have been associated with Pembrolizumab.

    FAQs – Medicine Questions

    Pembrolizumab Injection 100 mg
    What is pembrolizumab used to treat?
    Pembrolizumab is used in: Patients whose cancer cannot be removed by surgery or has metastasized (spread to other parts of the body). Adults and children aged 12 years and older with stage IIB, stage IIC, or stage III melanoma. It is used to prevent melanoma from coming back after it has been removed by surgery.
    When is pembrolizumab given?
    How Pembrolizumab Is Given: Pembrolizumab is given as an intravenous injection through a vein (IV) over 30 minutes every 3 weeks. You may receive medications before the infusion to reduce allergic reactions.
    Is pembrolizumab a chemo drug?

    KEYTRUDA is not chemotherapy or radiation therapy—it is an immunotherapy and it works with your immune system to help fight cancer.

    Where can I buy Pembrolizumab Injection?

    You can buy Pembrolizumab Injection from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

    The buyer should check the existing law in their home country before importing the product.

    What is the procedure to buy Pembrolizumab Injection?

    Patients can simply fill the order form or can send mail at info@treatmentoptions4u.com. Patients can also send WhatsApp messages to +91 99292 77766 / 98738 10020   We will reply ASAP with the details of the Pembrolizumab Injection price as well as procurement procedure.

    Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

    Does pembrolizumab cause hair loss?
    Nearly 11 out of 100 people in the pembrolizumab group experienced hair loss, compared with 59 out of 100 people in the docetaxel group. Mouth and tongue sores affected about 22 out of 100 people who took pembrolizumab, and nearly 32 out of 100 people in the standard treatment group.

    NEWS / UPDATES

    1. Merck Sharp & Dohme (UK) Limited, Electronic medicines compendium (emc), [Revised on Nov 2021] [ Accessed on 6th Dec 2021], https://www.medicines.org.uk/emc/files/pil.2498.pdf
    2. Merck Sharp & Dohme Corp, US Food and Drug administration, [Revised on Jan 2020] [ Accessed on 6th Dec 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125514s066lbl.pdf
    3. Leila Khoja et al; Pembrolizumab; Journal of Immunotherapy of Cancer; Published on Aug 2015; Accessed on 06/12/2021; https://pubmed.ncbi.nlm.nih.gov/26288737/
    4. Gerry Kwok et al; Pembrolizumab (Keytruda); Human Vaccines & Immunotherapeutics; Published on Nov 2016; Accessed on 06/12/2021; https://pubmed.ncbi.nlm.nih.gov/27398650/